The Beauty Health Company (NASDAQ: SKIN) reported Q3 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $70.7 million versus the consensus estimate of $68.49 million.

For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.